Glaukos (NYSE:GKOS) announced today that it entered into a collaboration and marketing agreement with Radius XR. Aliso Viejo, California-based Glaukos becomes the exclusive sales agent for the Radius XR wearable patient engagement and diagnostic system. The agreement gives the company the rights to market, promote and solicit orders for the platform in the U.S. Under […]
Optical/Ophthalmic
Bausch + Lomb makes another eye drop acquisition
Bausch + Lomb (NYSE:BLCO) announced today that an affiliate purchased the Blink product line from Johnson & Johnson Vision. The over-the-counter Blink product line features eye and contact lens drops, marking another eye care acquisition for Bausch + Lomb. Last week, the company acquired eye drops and a delivery system from Novartis in a deal worth up to […]
Bausch + Lomb acquires XIIDRA eye drops, delivery system from Novartis in $2.5B deal
Bausch + Lomb (NYSE:BLCO) announced today that it agreed to acquire XIIDRA non-steroid eye drops from Novartis. The company also acquired an investigational medicine and rights to a delivery device for treating dry eye disease (DED). AcuStream, an investigational device that may have the potential to facilitate precise dosing and accurate delivery of certain topical […]
Luminopia raises $16M for digital lazy eye therapeutic
Luminopia announced that it raised $16 million to support its software-based therapeutic for amblyopia, commonly known as lazy eye. Cambridge, Massachusetts-based Luminopia saw its oversubscribed Series A financing round led by U.S. Venture Partners (USVP). New investor Broadfin Advisors supported alongside existing investors ShangBay Capital and Vertical Group. In conjunction with the financing. USVP General […]
Precision Lens, owner hit with $487M judgement in kickbacks case
A U.S. District Judge entered a judgment against Precision Lens and its owner, Paul Ehlen, for more than $487 million in a kickback case. Judge Wilhelmina M. Wright’s decision follows a verdict handed down by a federal jury in Minnesota earlier this year. The jury concluded that the defendants violated the False Claims Act and […]
FDA approves ophthalmic spray from Eyenovia
Eyenovia (Nasdaq:EYEN) announced today that the FDA approved its Mydcombi treatment for use with the Optejet delivery device. New York-based Eyenovia designed Mydcombi (tropicamide and phenylephrine hydrochloride ophthalmic spray) 1%/2.5% for inducing mydriasis for diagnostic procedures and in conditions where short-term pupil dilation is desired. It marks the first approved fixed-dose combination of tropicamide and […]
Glaukos stock rises on 9% Q1 revenue growth
Glaukos (NYSE:GKOS) shares ticked up this morning on first-quarter results that came in mixed compared to the consensus forecast. Shares of GKOS rose 9% at $50.66 apiece as the market opened today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — dipped 0.03%. The (LOCATION)-based company posted losses […]
FDA clears iTrack Advance canaloplasty device from Nova Eye Medical
Nova Eye Medical announced today that it received FDA 510(k) clearance for its new iTrack Advance canaloplasty device. The FDA cleared iTrack Advance for microcatheterization and viscodilation to reduce intraocular pressure (IOP). It treats adult patients with primary open-angle glaucoma. Fremont, California-based Nova Eye designed its newest canaloplasty device to leverage the proprietary features of […]
Celanese to provide drug delivery platform for Glaukos glaucoma treatment
Celanese (NYSE:CE) announced today that it entered into an agreement with Glaukos (NYSE:GKOS) over drug delivery for glaucoma treatments. Dallas-based Celanese agreed to supply its VitalDose drug delivery platform for use as a component in Gluakos’ iDose TR. The iDose TR serves as a micro-invasive intraocular implant for lowering intraocular pressure. It treats patients with […]
Sight Sciences appoints new CFO
Sight Sciences (Nasdaq:SGHT) announced that it appointed Alison “Ali” Bauerlein as its chief financial officer and treasurer. Bauerlein’s appointment became effective on April 3. She joins from Inogen, having cofounded the medtech company in 2001 and served as CFO from 2009 through 2021. In that role, she oversaw the global finance and accounting functions, helping […]
Pixium Vision wins FDA breakthrough designation for dry AMD treatment device
Pixium Vision announced today that it received FDA breakthrough device designation for its Prima System for partially restoring vision. The Prima System, a photovoltaic substitute of photoreceptors, provides simultaneous use of the central prosthetic and peripheral natural vision. The company designed the implant for patients with atrophic dry age-related macular degeneration (AMD). It aims to […]